These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 14507636

  • 1. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
    Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB.
    Am J Pathol; 2003 Oct; 163(4):1261-73. PubMed ID: 14507636
    [Abstract] [Full Text] [Related]

  • 2. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
    Jung ES, Lee J, Heo NJ, Kim S, Kim DK, Joo KW, Han JS.
    Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
    [Abstract] [Full Text] [Related]

  • 3. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A.
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [Abstract] [Full Text] [Related]

  • 4. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
    Chung S, Jeong JY, Chang YK, Choi DE, Na KR, Lim BJ, Lee KW.
    Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402
    [Abstract] [Full Text] [Related]

  • 5. Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO mice.
    Tasanarong A, Kongkham S, Duangchana S, Thitiarchakul S, Eiam-Ong S.
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S1-9. PubMed ID: 22619900
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction.
    Hwang M, Kim HJ, Noh HJ, Chang YC, Chae YM, Kim KH, Jeon JP, Lee TS, Oh HK, Lee YS, Park KK.
    Exp Mol Pathol; 2006 Aug; 81(1):48-54. PubMed ID: 16443218
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.
    Kim CS, Kim IJ, Bae EH, Ma SK, Lee J, Kim SW.
    PLoS One; 2015 Aug; 10(11):e0142664. PubMed ID: 26556707
    [Abstract] [Full Text] [Related]

  • 8. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy.
    Zhang G, Kim H, Cai X, López-Guisa JM, Alpers CE, Liu Y, Carmeliet P, Eddy AA.
    J Am Soc Nephrol; 2003 May; 14(5):1254-71. PubMed ID: 12707394
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction.
    Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S.
    Kidney Int; 1995 May; 47(5):1285-94. PubMed ID: 7637258
    [Abstract] [Full Text] [Related]

  • 10. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
    Liu Z, Huang XR, Chen HY, Penninger JM, Lan HY.
    Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of Tubular Injury and Renal Fibrosis by TI-HU-YIN via Reduction in Transforming Growth Factor-β1 Expression in Unilateral Ureteral Obstruction Mice.
    Tarng DC, Liu IS, Lin LC, Chen NJ.
    Chin J Physiol; 2015 Dec 31; 58(6):367-76. PubMed ID: 26717915
    [Abstract] [Full Text] [Related]

  • 12. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK.
    Kidney Int; 2006 Oct 31; 70(7):1234-43. PubMed ID: 16929250
    [Abstract] [Full Text] [Related]

  • 13. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney.
    Ma FY, Han Y, Ozols E, Chew P, Vesey DA, Gobe GC, Morais C, Lohman RJ, Suen JY, Johnson DW, Fairlie DP, Nikolic-Paterson DJ.
    Nephrology (Carlton); 2019 Sep 31; 24(9):983-991. PubMed ID: 31314137
    [Abstract] [Full Text] [Related]

  • 14. Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy.
    Pimentel JL, Sundell CL, Wang S, Kopp JB, Montero A, Martínez-Maldonado M.
    Kidney Int; 1995 Oct 31; 48(4):1233-46. PubMed ID: 8569085
    [Abstract] [Full Text] [Related]

  • 15. Effects of exendin-4 on the intrarenal renin-angiotensin system and interstitial fibrosis in unilateral ureteral obstruction mice: Exendin-4 and unilateral ureteral obstruction.
    Le Y, Zheng Z, Xue J, Cheng M, Guan M, Xue Y.
    J Renin Angiotensin Aldosterone Syst; 2016 Oct 31; 17(4):. PubMed ID: 27913661
    [Abstract] [Full Text] [Related]

  • 16. ASK1/p38 signaling in renal tubular epithelial cells promotes renal fibrosis in the mouse obstructed kidney.
    Ma FY, Tesch GH, Nikolic-Paterson DJ.
    Am J Physiol Renal Physiol; 2014 Dec 01; 307(11):F1263-73. PubMed ID: 25298527
    [Abstract] [Full Text] [Related]

  • 17. Expression of connective tissue growth factor in renal tubulointerstitial fibrosis in rats and its pathogenic role.
    Zhang C, Zhu Z, Liu J, Yang X, Fu L, Deng A, Meng X.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Dec 01; 25(5):519-22. PubMed ID: 16463662
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
    Yang F, Chung AC, Huang XR, Lan HY.
    Hypertension; 2009 Oct 01; 54(4):877-84. PubMed ID: 19667256
    [Abstract] [Full Text] [Related]

  • 19. Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-beta1 expression in acute ureteral obstruction.
    Shin GT, Kim WH, Yim H, Kim MS, Kim H.
    Kidney Int; 2005 Mar 01; 67(3):897-908. PubMed ID: 15698429
    [Abstract] [Full Text] [Related]

  • 20. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
    Hewitson TD, Mookerjee I, Masterson R, Zhao C, Tregear GW, Becker GJ, Samuel CS.
    Endocrinology; 2007 Feb 01; 148(2):660-9. PubMed ID: 17095590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.